Differentiation and plasticity of stem cells for tissue engineering

Tissue Engineering: From Lab to Clinic

Volumn 9783642028243, Issue , 2011, Pages 113-130

  Song, Yao Hua ^a   Prantl, Lukas ^a,b   Alt, Eckhard ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL CULTURE; FLOWCHARTING; STEM CELLS; TISSUE; TISSUE ENGINEERING;

ADIPOSE TISSUE; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEMS; MATURE CELLS; MESENCHYMAL STEM CELL; SINGLE-CELL LEVEL; UNDIFFERENTIATED CELLS; WEAR AND TEAR;

CELL ENGINEERING;

EID: 84871846327     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-02824-3_7     Document Type: Chapter

References (126)

1. Abbott JD et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110(21): 3300-5.
2. Alt E, et al. Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. Int J Cardiol. 2009; doi:10.1016/j.ijcard.2009.03.12.
3. Altman AM et al. Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials. 2008;29(10):1431-42.
4. Altman AM et al. Human adipose-derived stem cells adhere to acellular dermal matrix. Aesthetic Plast Surg. 2008;32(4): 698-9.
5. Altman AM et al. IFATS collection: Human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells. 2009;27(1):250-8.
6. Amado LC et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005;102(32): 11474-9.
7. Amos PJ, et al. IFATS series: The role of human adiposederived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells. 2008;26(10):2682-90.
8. Assmus B et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106(24):3009-17.
9. Bai X, Yan Y, Song YH, Seidensticker M, Rabinovich B, Metzele R, Bankson JA, Vykoukal D, Alt E. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J. 2010;31(4):489-501. Epub 2009 Dec 25.PMID: 20037143.
10. Bai X et al. Genetically selected stem cells from human adipose tissue express cardiac markers. Biochem Biophys Res Commun. 2007;353(3):665-71.
11. Bai X et al. Electrophysiological properties of human adipose tissue-derived stem cells. Am J Physiol Cell Physiol. 2007;293(5):C1539-50.
12. Bartholomew A et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30(1):42-8.
13. Bi Y et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007;13(10):1219-27.
14. Billings Jr E, May Jr JW. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg. 1989;83(2):368-81.
15. Breitbach M et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110(4): 1362-9.
16. Bunnell BA et al. Differentiation of adipose stem cells. Methods Mol Biol. 2008;456:155-71.
17. Cao JM et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation. 2000; 101(16):1960-9.
18. Cho SW et al. Engineering of volume-stable adipose tissues. Biomaterials. 2005;26(17):3577-85.
19. Corre J et al. Human subcutaneous adipose cells support complete differentiation but not self-renewal of hematopoietic progenitors. J Cell Physiol. 2006;208(2):282-8.
20. Cousin B et al. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun. 2003;301(4):1016-22.
21. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest. 2005;115(3):572-83.
22. Dominici M et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7.
23. Erickson GR et al. Chondrogenic potential of adipose tissuederived stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;290(2):763-9.
24. Ferrari G et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279(5356):1528-30.
25. Fotuhi P, Song YH, Alt E. Electrophysiological consequence of adipose-derived stem cell transplantation in infarcted porcine myocardium. Europace. 2007;9(12):1218-21.
26. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation. 2004; 110(21):3378-83.
27. Freyman T et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9): 1114-22.
28. Friedenstein AJ et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2(2):83-92.
29. Garcia-Dorado D et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993;27(8):1462-9.
30. Garcion E et al. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development. 2004;131(14):3423-32.
31. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249-60.
32. Gnecchi M et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11(4):367-8.
33. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood. 1995;85(4): 929-40.
34. Guilak F et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol. 2006;206(1):229-37.
35. Halvorsen YC, Gimble JM. Adipose-derived stromal cells- Their utility and potential in bone formation. Int J Obes Relat Metab Disord. 2000;24 Suppl 4:S41-4.
36. Halvorsen YD et al. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism. 2001;50(4):407-13.
37. Hickerson WL, et al. Cultured epidermal autografts and allodermis combination for permanent burn wound coverage. Burns. 1994;20(Suppl 1):S52-5; discussion S55-6.
38. Hofmann M et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005; 111(17):2198-202.
39. Huang JI, et al. Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. Plast Reconstr Surg. 2002;109(3):1033-41; discussion 1042-3.
40. Izumi K, et al. Ex vivo development of a composite human oral mucosal equivalent. J Oral Maxillofac Surg. 1999;57(5): 571-7; discussion 577-8.
41. Jensen UB, Lowell S, Watt FM. The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: A new view based on whole-mount labelling and lineage analysis. Development. 1999;126(11): 2409-18.
42. Jiang Y et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41-9.
43. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 1993;73(4): 713-24.
44. Kajstura J et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005;96(1):127-37.
45. Kamihata H et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001; 104(9):1046-52.
46. Kang SK et al. Neurogenesis of Rhesus adipose stromal cells. J Cell Sci. 2004;117(Pt 18):4289-99.
47. Kiger AA et al. Stem cell self-renewal specified by JAKSTAT activation in response to a support cell cue. Science. 2001;294(5551):2542-5.
48. Kilroy GE et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and proinflammatory factors. J Cell Physiol. 2007;212(3):702-9.
49. Kim WS et al. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48(1):15-24.
50. Kim Y et al. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem. 2007;20(6):867-76.
51. Kocher AA et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7(4):430-6.
52. Krampera M et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101(9): 3722-9.
53. Krampera M et al. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone. 2007;40(2):382-90.
54. Kuethe F et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol. 2004;97(1):123-27.
55. Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol. 1997;97(3):561-70.
56. Kuznetsov SA et al. Circulating skeletal stem cells. J Cell Biol. 2001;153(5):1133-40.
57. Lee JH, Kemp DM. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun. 2006;341(3):882-8.
58. Lee RH et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54-63.
59. Liechty KW et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000;6(11):1282-6.
60. Locklin RM, Oreffo RO, Triffitt JT. Effects of TGFbeta and bFGF on the differentiation of human bone marrow stromal fibroblasts. Cell Biol Int. 1999;23(3):185-94.
61. Losordo DW et al. Phase 1/2 placebo-controlled, doubleblind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 2002;105(17):2012-8.
62. Makino S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103(5): 697-705.
63. Mangi AA et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9(9):1195-201.
64. Martin I et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 1997;138(10):4456-62.
65. Martin-Rendon E et al. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang. 2008;95(2): 137-48.
66. McIntosh K et al. The immunogenicity of human adiposederived cells: Temporal changes in vitro. Stem Cells. 2006;24(5):1246-53.
67. Miranville A et al. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004;110(3):349-55.
68. Mitchell JB et al. Immunophenotype of human adiposederived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2006;24(2): 376-85.
69. Miyahara Y et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006;12(4):459-65.
70. Moelker AD et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J Mol Cell Cardiol. 2007;42(4):735-45.
71. Muehlberg F et al. Tissue resident stem cells promote breast cancer growth and metastasis. Carcinogenesis. 2009;30(4): 589-97.
72. Musaro A et al. Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci USA. 2004;101(5):1206-10.
73. Nuttall ME et al. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res. 1998;13(3):371-82.
74. Oedayrajsingh-Varma MJ et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8(2):166-77.
75. Oreffo RO et al. Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro. J Cell Biochem. 1999;74(3):372-85.
76. Orlic D et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-5.
77. Orlic D et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98(18):10344-9.
78. Osawa M et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273(5272):242-5.
79. Park SR, Oreffo RO, Triffitt JT. Interconversion potential of cloned human marrow adipocytes in vitro. Bone. 1999;24(6): 549-54.
80. Pinilla S et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. 2009;284(1): 80-5.
81. Pittenger MF et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-7.
82. Planat-Benard V et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109(5):656-63.
83. Pricola KL et al. Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem. 2009;108(3):577-88.
84. Rangappa S et al. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg. 2003; 126(1):124-32.
85. Rehman J et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004; 109(10):1292-8.
86. Reyes M et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98(9):2615-25.
87. Rickard DJ et al. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol. 1994;161(1):218-28.
88. Rochitte CE et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 1998;98(10):1006-14.
89. Ryden M et al. Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochem Biophys Res Commun. 2003;311(2):391-7.
90. Sadat S et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 2007;363(3):674-9.
91. Safford KM et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002;294(2):371-9.
92. Sanchez-Ramos J et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2): 247-56.
93. Schimrosczyk K et al. Liposome-mediated transfection with extract from neonatal rat cardiomyocytes induces transdifferentiation of human adipose-derived stem cells into cardiomyocytes. Scand J Clin Lab Invest. 2008;68(6): 464-72.
94. Scutt A, Zeschnigk M, Bertram P. PGE2 induces the transition from non-adherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism. Prostaglandins. 1995;49(6):383-95.
95. Sekiya I et al. Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res. 2004;19(2):256-64.
96. Sen A et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem. 2001;81(2):312-9.
97. Seo MJ et al. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun. 2005;328(1):258-64.
98. Shim WS et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun. 2004;324(2):481-8.
99. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241(4861):58-62.
100. Sutherland HJ et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood. 1989;74(5):1563-70.
101. Talens-Visconti R et al. Human mesenchymal stem cells from adipose tissue: differentiation into hepatic lineage. Toxicol In Vitro. 2007;21(2):324-9.
102. Timper K et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun. 2006;341(4):1135-40.
103. Toma C et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93-8.
104. Traktuev DO et al. A population of multipotent CD34- positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res. 2008;102(1): 77-85.
105. Tsutsumi S et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001; 288(2):413-9.
106. Tulina N, Matunis E. Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science. 2001;294(5551):2546-9.
107. Valina C et al. Intracoronary administration of autologous adipose tissue derived stem cells improves left ventricular function. Perfusion and remodeling after acute myocardial infarction. Eur Heart J. 2007;28:2667-77.
108. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422(6934):901-4.
109. von Heimburg D et al. Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells. Respir Physiol Neurobiol. 2005;146(2-3):107-16.
110. Vulliet PR et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363(9411):783-4.
111. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18(12):1417-26.
112. Walsh S et al. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone. 2000;27(2):185-95.
113. Walsh S et al. TGFbeta1 limits the expansion of the osteoprogenitor fraction in cultures of human bone marrow stromal cells. Cell Tissue Res. 2003;311(2):187-98.
114. Wang EA et al. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors. 1993;9(1):57-71.
115. Wang JS et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 2000;120(5):999-1005.
116. Wang X et al. Cell fusion is the principal source of bone-marrow- derived hepatocytes. Nature. 2003;422(6934):897-901.
117. Wehling N et al. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum. 2009;60(3):801-12.
118. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. 2000; 287(5457):1442-6.
119. Wickham MQ, et al. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res. 2003;(412):196-212.
120. Wollert KC et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet. 2004;364(9429):141-8.
121. Yoon J et al. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiol. 2005;60(3):277-84.
122. Young HE et al. Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC class-I. Proc Soc Exp Biol Med. 1999;221(1):63-71.
123. Yuan A et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One. 2009;4(3):e4722.
124. Yuasa S et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol. 2005;23(5):607-11.
125. Zuk PA et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7(2): 211-28.
126. Zuk PA et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-95.